Therapeutic drug monitoring of amikacin in septic patients

INTRODUCTION: Use of higher than standard doses of amikacin (AMK) has been proposed during sepsis, especially to treat less susceptible bacterial strains. However, few data are available on drug concentrations during prolonged therapy and on potential adverse events related to this strategy. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Duszynska, Wieslawa, Taccone, Fabio Silvio, Hurkacz, Magdalena, Kowalska-Krochmal, Beata, Wiela-Hojeńska, Anna, Kübler, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057344/
https://www.ncbi.nlm.nih.gov/pubmed/23886243
http://dx.doi.org/10.1186/cc12844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057344/
https://www.ncbi.nlm.nih.gov/pubmed/23886243
http://dx.doi.org/10.1186/cc12844

Ejemplares similares